Kamar, Nassim <br/><br/>
Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Aug 2010 
 - 2792-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfq282  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Chronic Disease<br/>Dose-Response Relationship, Drug<br/>Hepatitis E--drug therapy<br/>Hepatitis E virus<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Kidney Failure, Chronic--therapy<br/>Kidney Transplantation--immunology<br/>Male<br/>Nephritis, Hereditary--surgery<br/>Opportunistic Infections--drug therapy<br/>Polyethylene Glycols--therapeutic use<br/>Recombinant Proteins<br/>Renal Dialysis<br/>Treatment Outcome